Cellectis (CLLS) Net Income (QoQ) (2015 - 2026)
Cellectis (CLLS) Net Income (QoQ) (2015 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Cellectis |
17.40 Bn |
17.21 Bn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
91.83% |
| Dec 31, 2025 |
-426.89% |
| Sep 30, 2025 |
52.45% |
| Jun 30, 2025 |
817.00% |
| Mar 31, 2025 |
104.20% |
| Dec 31, 2024 |
-263.95% |
| Jun 30, 2023 |
378.90% |
| Mar 31, 2023 |
-64.19% |
| Dec 31, 2022 |
50.03% |
| Sep 30, 2022 |
-1,193.67% |
| Jun 30, 2022 |
93.14% |
| Mar 31, 2022 |
3.13% |
| Dec 31, 2021 |
84.31% |
| Sep 30, 2021 |
-13.04% |
| Jun 30, 2021 |
-273.76% |
| Mar 31, 2021 |
74.39% |
| Dec 31, 2020 |
-33.42% |
| Sep 30, 2020 |
11.13% |
| Jun 30, 2020 |
-329.19% |
| Mar 31, 2020 |
137.44% |
